275 related articles for article (PubMed ID: 19267860)
1. Mechanisms of penile fibrosis.
Gonzalez-Cadavid NF
J Sex Med; 2009 Mar; 6 Suppl 3():353-62. PubMed ID: 19267860
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathophysiology and gene therapy of aging-related erectile dysfunction.
Gonzalez-Cadavid NF; Rajfer J
Exp Gerontol; 2004; 39(11-12):1705-12. PubMed ID: 15582286
[TBL] [Abstract][Full Text] [Related]
3. The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective.
Gonzalez-Cadavid NF; Rajfer J
Int J Impot Res; 2019 Mar; 31(2):57-60. PubMed ID: 30258189
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.
Vernet D; Ferrini MG; Valente EG; Magee TR; Bou-Gharios G; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 Dec; 7(4):262-76. PubMed ID: 12446175
[TBL] [Abstract][Full Text] [Related]
5. Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?
Chung E; De Young L; Brock GB
J Sex Med; 2011 Dec; 8(12):3446-51. PubMed ID: 21981553
[TBL] [Abstract][Full Text] [Related]
6. Experimental models of Peyronie's disease. Implications for new therapies.
Gonzalez-Cadavid NF; Rajfer J
J Sex Med; 2009 Feb; 6(2):303-13. PubMed ID: 19138365
[TBL] [Abstract][Full Text] [Related]
7. Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu.
Kovanecz I; Vernet D; Masouminia M; Gelfand R; Loni L; Aboagye J; Tsao J; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2016 May; 13(5):786-97. PubMed ID: 27114192
[TBL] [Abstract][Full Text] [Related]
8. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes.
Ferrini MG; Rivera S; Moon J; Vernet D; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2010 Sep; 7(9):3033-44. PubMed ID: 20626593
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.
Gonzalez-Cadavid NF; Rajfer J
Nat Rev Urol; 2010 Apr; 7(4):215-21. PubMed ID: 20212516
[TBL] [Abstract][Full Text] [Related]
10. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
11. Peyronie's disease: epidemiology, diagnosis, and management.
Miner MM; Seftel AD
Curr Med Res Opin; 2014 Jan; 30(1):113-20. PubMed ID: 24040888
[TBL] [Abstract][Full Text] [Related]
12. Reversion of penile fibrosis: Current information and a new horizon.
El-Sakka AI
Arab J Urol; 2011 Mar; 9(1):49-55. PubMed ID: 26579268
[TBL] [Abstract][Full Text] [Related]
13. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
Ferrini MG; Kovanecz I; Sanchez S; Vernet D; Davila HH; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.
Gonzalez-Cadavid NF; Rajfer J
Nat Clin Pract Urol; 2005 Jun; 2(6):291-7. PubMed ID: 16474811
[TBL] [Abstract][Full Text] [Related]
15. Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease.
Bivalacqua TJ; Champion HC; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):345-52. PubMed ID: 12454685
[TBL] [Abstract][Full Text] [Related]
16. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study.
Usta MF; Bivalacqua TJ; Tokatli Z; Rivera F; Gulkesen KH; Sikka SC; Hellstrom WJ
J Urol; 2004 Jul; 172(1):259-62. PubMed ID: 15201789
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.
Ferrini MG; Kovanecz I; Sanchez S; Umeh C; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2009 Feb; 6(2):415-28. PubMed ID: 19138364
[TBL] [Abstract][Full Text] [Related]
18. Vasculogenic erectile dysfunction: newer therapeutic strategies.
Siroky MB; Azadzoi KM
J Urol; 2003 Aug; 170(2 Pt 2):S24-9; discussion S29-30. PubMed ID: 12853769
[TBL] [Abstract][Full Text] [Related]
19. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction.
Kovanecz I; Nolazco G; Ferrini MG; Toblli JE; Heydarkhan S; Vernet D; Rajfer J; Gonzalez-Cadavid NF
BJU Int; 2009 May; 103(10):1396-404. PubMed ID: 19154511
[TBL] [Abstract][Full Text] [Related]
20. Profibrotic role of myostatin in Peyronie's disease.
Cantini LP; Ferrini MG; Vernet D; Magee TR; Qian A; Gelfand RA; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2008 Jul; 5(7):1607-22. PubMed ID: 18422491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
